Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-02

FDA Approved: NADOLOL — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Nadolol under an Original Application from Alembic Pharmaceuticals Limited, authorizing a generic Nadolol product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nadolol (Nadolol)

Snippet

ORIG AP for NADOLOL (NADOLOL)